Eloxx Pharmaceuticals Announces New Development Program for ELX-02 for the Treatment of Alport Syndrome
Strong rationale for development for Alport syndrome as ELOX-02 has demonstrated significant readthrough in COL4A5…
News
Icosavax Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update
– Completed dosing in older adults portion of Phase 1/1b clinical trial for IVX-121, a…
Agile Therapeutics Reports Fourth Quarter & Full Year 2021 Financial Results and Provides Corporate Update
Twirla Demand Grows with Cycles Dispensed and Total Prescriptions (TRx) Up 35% and 33% Respectively…
Bolt Biotherapeutics Reports Four Quarter and Full Year 2021 Financial Results and Provides Business Highlights
BDC-1001 for the treatment of patients with HER2-expressing solid tumors on track for recommended Phase…
RVL Pharmaceuticals plc Reports Fourth Quarter and Full Year 2021 Financial Results; Provides Preliminary First Quarter 2022 UPNEEQ® Revenue Estimate and Business Update
Fourth quarter 2021 UPNEEQ product sales of $3.1 million, representing 39% growth over third quarter…
Clarus Therapeutics Reports Fourth Quarter and Full Year 2021 Financial and Operating Results
2021 net revenue increased 119% year-over-year to $14.0 million Fourth quarter 2021 net revenue increased…
Angion Provides Corporate Update and Reports Full Year 2021 Financial Results
— Enrollment continues in Phase 2 JUNIPER trial of ANG-3070 for the treatment of patients…
Crinetics Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results
– Pipeline Includes Three New Chemical Entities with Clinical Proof-Of-Concept (POC) Following CRN04894 and CRN04777…
Centessa Pharmaceuticals Reports Fourth Quarter and 2021 Financial Results and Provides Business Update
– Company strengthens strategic focus on rare disease and immuno-oncology assets and details expected upcoming…
Crinetics Pharmaceuticals Reports Positive Top-Line Results from CRN04777 Phase 1 Study Multiple-Ascending Dose Cohorts
Results Further Support Clinical Proof-of-Concept for CRN04777 by Showing Dose-Dependent Decreases in Fasting and Sulfonylurea-Induced…
LBank Exchange Will List Cryptounit (CRU) on March 30, 2022
Internet City, Dubai–(Newsfile Corp. – March 30, 2022) – LBank Exchange, a global digital asset…
Weimob (2013.HK) Smart Retail sends SaaS revenues soaring 90.9%
SHANGHAI, Mar 31, 2022 – (ACN Newswire) – Weimob Inc (2013.HK) released its 2021 financial…
Siebert Reports Fourth Quarter and Full Year 2021 Financial Results
Revenue Growth of 23% for Full Year 2021 Operating Income Growth of 111% for Full…
Appgate Announces Fourth Quarter and Full Year 2021 Financial Results
Fourth quarter revenue of $13.9 million, an increase of 36% year-over-year Annual recurring revenue (ARR)…
IQVIA Selected to Support EMA’s DARWIN EU® Coordination Centre Initiative
AMSTERDAM–(BUSINESS WIRE)–IQVIA™ (NYSE:IQV), a leading global provider of advanced analytics, technology solutions and clinical research…
Spirit Realty Capital, Inc. Announces $1.2 Billion Revolving Credit Facility
DALLAS–(BUSINESS WIRE)–Spirit Realty Capital, Inc. (NYSE: SRC) (“Spirit” or the “Company”), a net-lease real estate…
NEC’s Information Security Management System Receives Global ISO 27001 Certification
NQA Accredits NEC’s Biometric and Identity Management Capabilities to Globally Recognized Security Standard IRVING, Texas–(BUSINESS…
FG Financial Group, Inc. Reports Fourth Quarter and Full-Year 2021 Financial Results
Company Continues to Advance SPAC Strategy and Grow Re-Insurance Premiums ST. PETERSBURG, Fla.–(BUSINESS WIRE)–FG Financial…
ENDRA Life Sciences Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
Conference call begins at 4:30 p.m. Eastern time today ANN ARBOR, Mich.–(BUSINESS WIRE)–$NDRA #NAFLD—ENDRA Life…
Symbotic Names Michael J. Loparco Chief Executive Officer
WILMINGTON, Mass.–(BUSINESS WIRE)–Symbotic LLC, a revolutionary A.I.-enabled technology platform provider for the supply chain and…